Cargando…
A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
BACKGROUND: There is significant interest in determining risk factors in individuals at risk of rheumatoid arthritis (RA). A core set of risk factors for clinical arthritis development has not been defined. METHODS: A literature search and systematic literature review (SLR) was conducted to identify...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449955/ https://www.ncbi.nlm.nih.gov/pubmed/34531306 http://dx.doi.org/10.1136/rmdopen-2021-001768 |
_version_ | 1784569521613307904 |
---|---|
author | Mankia, Kulveer Siddle, Heidi Di Matteo, Andrea Alpízar-Rodríguez, Deshiré Kerry, Joel Kerschbaumer, Andreas Aletaha, Daniel Emery, Paul |
author_facet | Mankia, Kulveer Siddle, Heidi Di Matteo, Andrea Alpízar-Rodríguez, Deshiré Kerry, Joel Kerschbaumer, Andreas Aletaha, Daniel Emery, Paul |
author_sort | Mankia, Kulveer |
collection | PubMed |
description | BACKGROUND: There is significant interest in determining risk factors in individuals at risk of rheumatoid arthritis (RA). A core set of risk factors for clinical arthritis development has not been defined. METHODS: A literature search and systematic literature review (SLR) was conducted to identify risk factors in individuals at risk of RA using Medline, Embase, PubMed and Central databases. RESULTS: 3854 articles were identified by the literature search. After screening of titles, 138 abstracts were reviewed and 96 articles finally included. Fifty-three articles included data on risk factors including autoantibodies, subclinical inflammation on imaging, clinical features, serum and cellular biomarkers and genetic markers. Risk factors were dependent on the at-risk population. There was good evidence for serum anticitrullinated protein antibodies (ACPA) levels, as risk factors for arthritis in all at-risk populations (n=13 articles). Subclinical inflammation on ultrasound (n=12) and MRI (n=6) was reported as a risk factor in multiple studies in at-risk individuals with musculoskeletal (MSK) symptoms and undifferentiated arthritis (UA). Clinical features were reported as a risk factor in at-risk individuals with MSK symptoms and UA (n=13). Other risk factors, including serum and cellular markers were less frequently reported. CONCLUSIONS: Risk factors for arthritis development in RA are specific to the at-risk population. Serum ACPA confers risk in all populations; subclinical inflammation on imaging and clinical features confer risk in at-risk individuals with MSK symptoms. This SLR informed the EULAR taskforce for points to consider on conducting clinical trials and studies in individuals at risk of RA. |
format | Online Article Text |
id | pubmed-8449955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-84499552021-10-01 A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis Mankia, Kulveer Siddle, Heidi Di Matteo, Andrea Alpízar-Rodríguez, Deshiré Kerry, Joel Kerschbaumer, Andreas Aletaha, Daniel Emery, Paul RMD Open Rheumatoid Arthritis BACKGROUND: There is significant interest in determining risk factors in individuals at risk of rheumatoid arthritis (RA). A core set of risk factors for clinical arthritis development has not been defined. METHODS: A literature search and systematic literature review (SLR) was conducted to identify risk factors in individuals at risk of RA using Medline, Embase, PubMed and Central databases. RESULTS: 3854 articles were identified by the literature search. After screening of titles, 138 abstracts were reviewed and 96 articles finally included. Fifty-three articles included data on risk factors including autoantibodies, subclinical inflammation on imaging, clinical features, serum and cellular biomarkers and genetic markers. Risk factors were dependent on the at-risk population. There was good evidence for serum anticitrullinated protein antibodies (ACPA) levels, as risk factors for arthritis in all at-risk populations (n=13 articles). Subclinical inflammation on ultrasound (n=12) and MRI (n=6) was reported as a risk factor in multiple studies in at-risk individuals with musculoskeletal (MSK) symptoms and undifferentiated arthritis (UA). Clinical features were reported as a risk factor in at-risk individuals with MSK symptoms and UA (n=13). Other risk factors, including serum and cellular markers were less frequently reported. CONCLUSIONS: Risk factors for arthritis development in RA are specific to the at-risk population. Serum ACPA confers risk in all populations; subclinical inflammation on imaging and clinical features confer risk in at-risk individuals with MSK symptoms. This SLR informed the EULAR taskforce for points to consider on conducting clinical trials and studies in individuals at risk of RA. BMJ Publishing Group 2021-09-16 /pmc/articles/PMC8449955/ /pubmed/34531306 http://dx.doi.org/10.1136/rmdopen-2021-001768 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Rheumatoid Arthritis Mankia, Kulveer Siddle, Heidi Di Matteo, Andrea Alpízar-Rodríguez, Deshiré Kerry, Joel Kerschbaumer, Andreas Aletaha, Daniel Emery, Paul A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
title | A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
title_full | A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
title_fullStr | A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
title_full_unstemmed | A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
title_short | A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
title_sort | core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the eular points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
topic | Rheumatoid Arthritis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449955/ https://www.ncbi.nlm.nih.gov/pubmed/34531306 http://dx.doi.org/10.1136/rmdopen-2021-001768 |
work_keys_str_mv | AT mankiakulveer acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT siddleheidi acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT dimatteoandrea acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT alpizarrodriguezdeshire acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT kerryjoel acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT kerschbaumerandreas acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT aletahadaniel acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT emerypaul acoresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT mankiakulveer coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT siddleheidi coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT dimatteoandrea coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT alpizarrodriguezdeshire coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT kerryjoel coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT kerschbaumerandreas coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT aletahadaniel coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis AT emerypaul coresetofriskfactorsinindividualsatriskofrheumatoidarthritisasystematicliteraturereviewinformingtheeularpointstoconsiderforconductingclinicaltrialsandobservationalstudiesinindividualsatriskofrheumatoidarthritis |